Your browser doesn't support javascript.
loading
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System.
Yegya-Raman, Nikhil; Friedes, Cole; Sun, Lova; Iocolano, Michelle; Kim, Kristine N; Doucette, Abigail; Cohen, Roger B; Robinson, Kyle W; Levin, William P; Cengel, Keith A; Lally, Brian; Agarwal, Manuj; D'Avella, Christopher A; Marmarelis, Melina E; Kosteva, John A; Singh, Aditi P; Ciunci, Christine A; Aggarwal, Charu; Berman, Abigail T; Langer, Corey J; Feigenberg, Steven J.
Afiliação
  • Yegya-Raman N; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: Nikhil.Yegya-Raman@pennmedicine.upenn.edu.
  • Friedes C; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Sun L; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Iocolano M; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Kim KN; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Doucette A; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Cohen RB; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Robinson KW; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Levin WP; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Cengel KA; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Lally B; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Agarwal M; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • D'Avella CA; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Marmarelis ME; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Kosteva JA; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Singh AP; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Ciunci CA; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Aggarwal C; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Berman AT; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Langer CJ; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Feigenberg SJ; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Clin Lung Cancer ; 24(5): 474-482, 2023 07.
Article em En | MEDLINE | ID: mdl-37076396

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article